These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9443609)

  • 1. Mitotic index in the subrenal capsule assay as an indicator of the chemosensitivity of ovarian cancer.
    Suonio E; Lipponen P; Mäenpää J; Syrjänen K; Kangas L; Tuomisto L
    Cancer Chemother Pharmacol; 1997; 41(1):15-21. PubMed ID: 9443609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The subrenal capsule assay and gynecological cancer: five years of experience.
    Mäenpää J; Kangas L; Söderström KO; Grönroos M
    Ann Chir Gynaecol Suppl; 1987; 202():83-7. PubMed ID: 2444148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of combination and single agent chemosensitivity prediction in ovarian carcinoma using the subrenal capsule xenograft assay (SRCA).
    Stratton JA; Rettenmaier MA; Kucera PR; Berman ML; DiSaia PJ
    Gynecol Oncol; 1988 Jul; 30(3):416-21. PubMed ID: 3391423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The subrenal capsule assay in selecting chemotherapy for ovarian cancer: a prospective randomized trial.
    Mäenpää JU; Heinonen E; Hinkka SM; Karnani P; Klemi PJ; Korpijaakko TA; Kuoppala TA; Laine AM; Lähde MA; Nuoranne EK
    Gynecol Oncol; 1995 Jun; 57(3):294-8. PubMed ID: 7774832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An experimental study on subrenal capsule assay (SRCA)--problems for the use of immunosuppressive agents].
    Kikuchi H; Asamura M; Gamoh M; Okuno M; Wakui A; Takahashi T
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2607-12. PubMed ID: 2774591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Responsiveness of gynecological malignancies to oral antitumor agents in subrenal capsule assay and individualization of oral adjuvant chemotherapy].
    Sekiguchi I; Suzuki M; Aida I; Tamada T; Nishida M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):437-42. PubMed ID: 2115558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumour effect of interferons, cytostatic drugs and their combinations in subrenal capsule assay (SRCA).
    Kangas L; Cantell K; Grönroos M; Mäenpää J; Perilä M
    Ann Chir Gynaecol Suppl; 1985; 199():60-3. PubMed ID: 2415035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subrenal capsule assay using nude mice].
    Kikuchi H; Asamura M; Gamoh M; Ohuchi H; Wakui A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):532-41. PubMed ID: 2321981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
    Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemosensitivity test and its clinical application].
    Inoue K
    Gan No Rinsho; 1989 Oct; 35(13):1535-40. PubMed ID: 2685394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of the chemosensitivity test by human tumor clonogenic assay and subrenal capsule assay].
    Terashima M
    Nihon Geka Gakkai Zasshi; 1987 Nov; 88(11):1554-64. PubMed ID: 3431536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical application of subrenal capsule assay in ovarian cancer].
    Maeda K; Ushijima H; Shimamoto T; Shigematsu T; Kurano A; Watanabe Y; Jimi S; Okadome M; Mashiba H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1896-902. PubMed ID: 2592813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subrenal capsule assay in choosing cytostatics for gynaecological tumours.
    Mäenpää J; Grönroos M; Kangas L
    Ann Chir Gynaecol Suppl; 1985; 199():28-30. PubMed ID: 3864390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental studies on the subrenal capsule assay as chemosensitivity test for nonsolid tumors].
    Sakamoto T; Ogino M; Yamamoto T; Mori H; Okinaga S; Arai K
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):415-21. PubMed ID: 2197356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of chemosensitivity in the 6-day subrenal capsule assay].
    Inoue K
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2423-30. PubMed ID: 3619455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer.
    Venesmaa P; Ylikorkala O
    Br J Cancer; 1991 Jan; 63(1):84-6. PubMed ID: 1899195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biochemical evaluation of oral squamous cell carcinoma growth by measurement of specific activity of succinate dehydrogenase in the subrenal capsule assay.
    Munakata H; Kayada Y; Kawahara M; Sakamoto T; Yoshiga K; Takada K
    Int J Oral Maxillofac Surg; 1995 Jun; 24(3):216-20. PubMed ID: 7594755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural effects of alpha and gamma interferons and cytostatics on ovarian cancer cells in the subrenal capsule assay (SRCA).
    Söderström KO; Mäenpää J; Cantell K; Kangas L; Grönroos M
    Ann Chir Gynaecol Suppl; 1985; 199():38-43. PubMed ID: 3933399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors.
    Levi FA; Blum JP; Lemaigre G; Bourut C; Reinberg A; Mathé G
    Cancer Res; 1984 Jun; 44(6):2660-7. PubMed ID: 6722799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.